CRIS Current Research Information System

RUZZI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.152
EU - Europa 1.465
NA - Nord America 1.293
Continente sconosciuto - Info sul continente non disponibili 165
AF - Africa 111
SA - Sud America 75
OC - Oceania 2
Totale 5.263
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.253
IT - Italia 801
CN - Cina 679
VN - Vietnam 606
SG - Singapore 419
DE - Germania 151
NL - Olanda 133
HK - Hong Kong 110
KR - Corea 102
FR - Francia 61
IN - India 61
GB - Regno Unito 60
BR - Brasile 54
BD - Bangladesh 49
CI - Costa d'Avorio 46
FI - Finlandia 45
SE - Svezia 45
RU - Federazione Russa 31
JP - Giappone 30
CH - Svizzera 26
IE - Irlanda 25
CA - Canada 20
ZA - Sudafrica 20
AT - Austria 18
PH - Filippine 13
IQ - Iraq 12
BG - Bulgaria 11
ID - Indonesia 11
TH - Thailandia 11
TR - Turchia 10
MX - Messico 9
SC - Seychelles 9
TG - Togo 9
EG - Egitto 8
UA - Ucraina 8
AR - Argentina 7
DK - Danimarca 7
JO - Giordania 7
DZ - Algeria 6
LT - Lituania 6
PK - Pakistan 5
PL - Polonia 5
TW - Taiwan 5
EC - Ecuador 4
ES - Italia 4
HR - Croazia 4
JM - Giamaica 4
MA - Marocco 4
MY - Malesia 4
RO - Romania 4
VE - Venezuela 4
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
AL - Albania 2
AU - Australia 2
BE - Belgio 2
CL - Cile 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
LI - Liechtenstein 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GI - Gibilterra 1
GM - Gambi 1
GP - Guadalupe 1
KG - Kirghizistan 1
KW - Kuwait 1
MN - Mongolia 1
MU - Mauritius 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
Totale 5.098
Salva come PNG Salva come JPEG
Città #
Singapore 306
Bologna 248
Hefei 222
Shanghai 174
Ashburn 158
Ho Chi Minh City 155
Hanoi 135
San Jose 122
Hong Kong 103
Seoul 95
Council Bluffs 89
Milan 65
Chandler 57
Frankfurt am Main 54
Dallas 51
Fairfield 48
Abidjan 46
Dong Ket 44
Beijing 41
Los Angeles 40
Boardman 38
Ann Arbor 37
Houston 36
Santa Clara 34
New York 30
Woodbridge 28
Lauterbourg 27
Dublin 25
Southend 25
Bern 24
Amsterdam 22
Casalecchio di Reno 22
Lappeenranta 20
Tokyo 20
Bengaluru 19
Helsinki 19
Seattle 17
Da Nang 16
Haiphong 16
Vienna 16
Johannesburg 15
Cambridge 14
Rimini 13
Rome 13
São Paulo 13
Turin 13
Wilmington 13
Can Tho 12
Guangzhou 12
Parma 12
Princeton 12
Bremen 11
Buffalo 11
Munich 11
San Giovanni in Persiceto 11
Sofia 11
Bắc Giang 10
Chicago 10
Jakarta 10
Naples 10
Falkenstein 9
Lomé 9
Modena 9
Biên Hòa 8
Redmond 8
Amman 7
Berlin 7
Kerpen 7
Kyiv 7
London 7
Long Xuyen 7
Moscow 7
Porto Recanati 7
Tongling 7
Vicenza 7
Baghdad 6
Bangkok 6
Chambersburg 6
Crocetta 6
Delhi 6
Ha Long 6
Redondo Beach 6
San Francisco 6
Turku 6
Bergamo 5
Bo 5
Bến Tre 5
Chennai 5
Cimitile 5
Dundee 5
Hải Dương 5
Montreal 5
Nanjing 5
Nuremberg 5
Piscataway 5
Thái Nguyên 5
Algiers 4
Ankara 4
Bluffdale 4
Boston 4
Totale 3.224
Salva come PNG Salva come JPEG
Nome #
IFN-γ and CD38 in Hyperprogressive Cancer Development 441
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft 345
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 326
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma 294
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R 248
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape 246
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) 244
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression 224
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma 219
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay 216
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 216
Cancer vaccines: Target antigens, vaccine platforms and preclinical models 213
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations 211
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes? 203
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy 191
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality 186
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research 186
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine 182
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma 166
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis 150
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches 132
IL-1 Family Members in Bone Sarcomas 120
5.8S rRNA forms and ribosome heterogeneity in breast cancer 101
Development of cellular models expressing cynomolgus (Macaca fascicularis) HER2 for the functional evaluation of cross-reactive anti-human HER2 response 86
Alternatives for fetal bovine serum (FBS) and sustainability of milk derivatives in cell culture 39
Requalified bovine milk as a sustainable supplement for cell cultures 38
Talazoparib engages innate immune activation via PARP trapping–dependent cGAS/STING activation in Ewing Sarcoma 20
HER-2 therapeutic vaccine is not hampered by concurrent HER-2 monoclonal antibody 20
Totale 5.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022224 0 13 11 8 21 27 7 22 30 28 35 22
2022/2023373 23 32 20 51 26 32 19 15 52 17 46 40
2023/2024370 16 9 31 27 25 25 17 186 9 12 3 10
2024/20251.030 37 85 68 52 84 51 115 75 25 138 104 196
2025/20262.671 254 421 206 213 216 108 232 89 456 189 133 154
2026/2027206 105 101 0 0 0 0 0 0 0 0 0 0
Totale 5.263